IR@PKUHSC  > 北京大学临床肿瘤学院  > 胸外科
学科主题临床医学
N-acetyltransferase 2 phenotype and risk of esophageal cancer: A meta analysis
Ma, Ruo-Lan1,2; Min, Li3,4; Chen, Duo5; Tao, Wei-Ping1; Ge, Wei1; Wu, Yao-Gui1
关键词N-acetyltransferase 2 esophageal cancer risk meta analysis
刊名CANCER BIOMARKERS
2013
DOI10.3233/CBM-130387
13期:6页:447-455
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]GENETIC POLYMORPHISMS ; LUNG-CANCER ; INDIAN POPULATION ; BLADDER-CANCER ; SUSCEPTIBILITY ; NAT2 ; N-ACETYLTRANSFERASE-2 ; ASSOCIATION ; EXPRESSION ; CARCINOMA
英文摘要

N-acetyltransferase 2 (NAT2) gene encodes a phase II enzyme taking part in detoxification of aromatic amines. Published studies have demonstrated that N-Acetyltransferase 2 (NAT2) phenotype is a risk factor of various cancers. Many studies have investigated the association between NAT2 phenotype and susceptibility to esophageal cancer but yielded controversial results. To derive a more precise estimation of this association, a meta-analysis was performed. Electronic databases (Pubmed/Medline, ISI Web of Science and China National Knowledge Infrastructure) in English and Chinese were searched. A total of 5 articles including 476 cases and 1,093 controls were included in this meta-analysis. Odds ratio (OR) with 95% confidence interval (95% CI) was used to evaluate intensity of associations. Pooling studies together, NAT2 slow acetylator phenotype was a significant risk factor of esophageal squamous cell cancer (OR = 1.35, 95% CI = 1.03-1.77, n = 5 studies) but not esophageal adenocarcinoma (OR = 0.97, 95% CI = 0.47-2.04, n = 2 studies). There was a significant association between NAT2 acetylator phenotypes and ESCC in South Asian populations (OR = 1.51, 95% CI = 1.03-2.20), but not in East Asian populations (OR = 1.19, 95% CI = 0.80-1.77). Significant association between NAT2 acetylator phenotypes and esophageal cancer was found in population-based control subgroup (OR = 1.63, 95% CI = 1.07-2.50) but not in hospital-based control subgroup (OR = 1.19, 95% CI = 0.84-1.69). There is a significant association between NAT2 acetylator phenotype and esophageal cancer in both smokers (OR = 1.681, 95% CI = 1.179-2.395) and non-smokers (OR = 1.614, 95% CI = 1.173-2.222). In conclusion, NAT2 slow acetylator phenotype was a significant risk factor of ESCC in Asian populations.

语种英语
WOS记录号WOS:000332476900007
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66854
专题北京大学临床肿瘤学院_胸外科
作者单位1.Wuhan Univ, Renmin Hosp, Ctr Oncol, Wuhan 430060, Hubei, Peoples R China
2.Peking Univ, Canc Hosp & Inst, Dept Thorac Surg 1, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China
3.Peking Univ, Canc Hosp & Inst, Dept Biochem, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China
4.Peking Univ, Canc Hosp & Inst, Dept Mol Biol, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China
5.Peking Univ, Canc Hosp & Inst, Dept Epidemiol, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Ma, Ruo-Lan,Min, Li,Chen, Duo,et al. N-acetyltransferase 2 phenotype and risk of esophageal cancer: A meta analysis[J]. CANCER BIOMARKERS,2013,13(6):447-455.
APA Ma, Ruo-Lan,Min, Li,Chen, Duo,Tao, Wei-Ping,Ge, Wei,&Wu, Yao-Gui.(2013).N-acetyltransferase 2 phenotype and risk of esophageal cancer: A meta analysis.CANCER BIOMARKERS,13(6),447-455.
MLA Ma, Ruo-Lan,et al."N-acetyltransferase 2 phenotype and risk of esophageal cancer: A meta analysis".CANCER BIOMARKERS 13.6(2013):447-455.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ma, Ruo-Lan]的文章
[Min, Li]的文章
[Chen, Duo]的文章
百度学术
百度学术中相似的文章
[Ma, Ruo-Lan]的文章
[Min, Li]的文章
[Chen, Duo]的文章
必应学术
必应学术中相似的文章
[Ma, Ruo-Lan]的文章
[Min, Li]的文章
[Chen, Duo]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。